Loading
Axim Biotechnologies, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Valencia Catalina, was filed 15 Oct 2024.
Axim Biotechnologies, Inc.: what insiders have been doing
Axim Biotechnologies, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Axim Biotechnologies, Inc. has published a filing in the past twelve months. The most recent one dates from 15 October 2024.
Our records for Axim Biotechnologies, Inc. go back to 2014, with 3 purchases and 2 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
14
Thresholds
n/a
Buy Volume
€100,310
3 ops. · all time
Sell Volume
€290M
2 ops. · all time
Since the insiders bought
- -76.8%Entry US$0.10 · Close at T+365 US$0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$70.5k
Gross profitUS$63.1k90% margin
EBITDA-US$2.5M-3480% margin
Net income-US$3.5M-4996.6% margin
Valuation
Beta-0.11
Balance sheet & cash
Market capUS$1.2M
Total debtUS$7.2M
Free Cash Flow-US$857.9k
Profitability & ownership
ROA-36.3%
% insiders22.4%
% institutions0.0%
Last declaration on 15 October 2024
Declarations14 total
1,086,216 sharesCommon StockSEC:0001096906-24-002004:0
Canonical exit: 29 Apr 2024 (T+90)
6,000,000 sharesCommon StockSEC:0001096906-22-002328:0
Canonical exit: 17 Jun 2020 (T+90)
3,861,004 shares@ US$0.0259100.0% of flowCommon StockSEC:0001096906-22-002075:0
Canonical exit: 22 Nov 2022 (T+90)
854,012 shares@ US$0.029100.0% of flowCommon StockSEC:0001096906-22-002027:0
50,000 shares0Common StockSEC:0001078782-18-000415:0
125,000 sharesCommon StockSEC:0001078782-16-002279:0
500,000 shares0Common StockSEC:0001078782-15-002094:0
125,000 shares0Common StockSEC:0001078782-15-002094:1
1,000,000 shares0Preferred StockSEC:0001078782-15-002094:2
1,000,000 shares0Preferred StockSEC:0001078782-15-002095:0
25,000 shares0Common StockSEC:0001078782-15-002095:1
2,000 shares0Common StockSEC:0001078782-15-000331:0
20,000,000 sharesCOMMON STOCKSEC:0001514955-14-000004:0
1,000,000 shares@ US$400.00PREFERRED STOCKSEC:0001514955-14-000004:1
14 of 14 declarations
About Axim Biotechnologies, Inc.
Axim Biotechnologies, Inc. is a company focused on developing biopharmaceutical products, particularly for pain management and cannabis-related diseases. It is listed on NASDAQ under the ticker symbol AXIM.
